Global Prophylactic HIV Drug Market Growing at 7.8% CAGR Through 2034
According to a new report from Intel Market Research, the global Prophylactic HIV Drug Market was valued at USD 3.45 billion in 2025 and is projected to reach USD 6.12 billion by 2034, growing at a robust CAGR of 7.8% during the forecast period. The market growth is driven by increasing global HIV prevalence, rising awareness of preventive healthcare, and government initiatives promoting PrEP...
0 Комментарии 0 Поделились 35 Просмотры 0 предпросмотр
BuzzingAbout https://www.buzzingabout.com